Revue Neurologique. 2016;172(1):14–26.
7. Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurology. 2013;70(2):183–190; Rosenthal LS, Dorsey ER. The benefits of exercise in Parkinson disease. JAMA Neurology. 2013;70(2): 156–157; Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson’s disease. New England Journal of Medicine. 2012;366(6):511–519.
8. Goldman SM. Environmental toxins and Parkinson’s disease. Annual Review of Pharmacology and Toxicology. 2014;54(1):141–164; Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine. 2006;355(9):896–908.
9. Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology. 2003;60(11):1756–1761; Parashos SA, Maraganore DM, O’Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clinic Proceedings. 2002;77(9):918–925; Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism & Related Disorders. 2006;12(1):35–41; Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry. 1999;14(10):866–874.
10. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017–1022; Beyer MK, Herlofson K, Aarsland D, Larsen JP. Causes of death in a community-based study of Parkinson’s disease. Acta Neurologica Scandinavica. 2001;103(1):7-11; Fall PA, Saleh A, Fredrickson M, Olsson J-E, Gran6rus A-K. Survival time, mortality, and cause of death in elderly patients with Parkinson’s disease: a 9-year follow-up. Movement Disorders. 2003;18(11): 1312–1316.
11. Parkinson J. An essay on the shaking palsy. Journal of Neuropsychiatry and Clinical Neurosciences. 2002;14(2):223–236.
12. The 20th century mortality files, 1901–2000. Office for National Statistics. March 11, 2011. https://webarchive.nationalarchives.gov. uk/20150908090558; www.ons.gov.uk/ons/publications/ re-reference-tables.html?edition=tcm%3A77-215593. Accessed January 22, 2019; Duvoisin RC, Schweitzer MD. Paralysis agitans mortality in England and Wales, 1855–1962. British Journal of Preventive and Social Medicine. 1966;20(1):27–33.
13. More C. Understanding the Industrial Revolution. 1st ed. Routledge; 2000.
14. Ritchie H. What the history of London’s air pollution can tell us about the future of today’s growing megacities. Our World in Data. June 20, 2017. https://ourworldindata.org/london-air-pollution. Accessed December 12, 2018; Roser M, Ritchie H. Fertilizer and pesticides. Our World in Data. 2019. https://ourworldindata.org/fertilizer-and-pesticides. Accessed March 25, 2019; Manganese: history and industry development. Metalpedia. http://metalpedia.asianmetal. com/metal/ manganese/history.shtml. Accessed March 28, 2019; Bell T. The history of steel: From Iron Age to electric arc furnaces. The Balance. www. thebalance.com/steel-history-2340172. Updated June 25, 2019. Accessed March 28, 2019; Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson’s disease. Neurotoxicology. 2012;33(2):178–188.
15. Roser M, Ritchie H. Fertilizer and pesticides. Our World in Data. https:// ourworldindata.org/ fertilizer-and-pesticides. Accessed March 25, 2019.
16. Ascherio A, Chen H, Weisskopf MG, et al. Pesticide exposure and risk for Parkinson’s disease. Annals of Neurology. 2006;60(2): 197–203; Semchuk KM, Love EJ, Lee RG. Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology. 1992;42(7):1328–1328; Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013;80(22):2035–2041; Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6): 866–872.
17. Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson’s disease. Neurotoxicology. 2012;33(2):178–188; Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson’s disease. BioEssays. 2002;24(4):308–318; Uversky VN. Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell and Tissue Research. 2004;318(1):225–241.
18. Hogue C. Trump administration delays bans of toxic solvents. Chemical & Engineering News. December 20, 2017. https://cen.acs.org/articles/95/ web/2017/12/Trump-administration-delays-bans-toxic.html. Accessed March 28, 2019.
19. Barringer F. E.P.A. charts risks of a ubiquitous chemical. New York Times. September 30, 2011; Vettel P. Worried about decaf coffee? Fears are groundless. Chicago Tribune. May 19, 1985. www.chicagotribune. com/news/ct-xpm-1985-05-19-8502010068-story.html. Accessed July 19, 2019.
20. What is Superfund? US Environmental Protection Agency. www.epa. gov/superfund/what-superfund. Updated November 30, 2018. Accessed March 28, 2019.
21. Record of decision: Modock Road Springs/DLS Sand and Gravel, Inc. Site, Town of Victor, Ontario County, New York, Site Number 8-35-013. New York State Department of Environmental Conservation. January 2010. www.dec.ny.gov/docs/remediation_hudson_pdf/ 835013rod.pdf. Accessed March 29, 2019.
22. Trichloroethylene. US Environmental Protection Agency. April 1992. www.epa.gov/sites/ production/files/2016-09/documents/ trichloroethylene.pdf. Updated January 2000. Accessed March 28, 2019.
23. Trichloroethylene (TCE) general fact sheet. In Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services. www.gsa.gov/cdnstatic/ Trichloroethylene_%28TCE%29_ NEW_general_fact_sheet.pdf. Accessed March 29, 2019.
24. Risk management for trichloroethylene (TCE). US Environmental Protection Agency. www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-trichloroethylene-tce. Updated December 14, 2017. Accessed November 16, 2018; Integrated Risk Information System: trichloroethylene. US Environmental Protection Agency. https:// cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199. Updated July 28, 2017. Accessed March 28, 2019.
25. Watts M. Paraquat. Pesticide Action Network Asia & the Pacific. February 2011. www.panna.org/sites/default/files/Paraquat%20 monograph%20final%202011-1.pdf. Accessed June 28, 2019; China about to ban all sales and use of paraquat by 2020 [пресс-релиз]. CCM Data & Business Intelligence, July 31, 2017. www.cnchemicals. com/Press/89866-China%20 about%20to%20ban%20all%20sales%20 and%20use%20of%20paraquat%20by%202020.html. Accessed June 28, 2019.
26. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6):866–872.
27. Pesticide National Synthesis Project: estimated annual agricultural pesticide use. US Geological Survey. https://water.usgs.gov/nawqa/pnsp/ usage /maps/show_map.php? year=2015&map=PARAQUAT&hilo=H. Updated September 11, 2018. Accessed March 25, 2019.
28. Jenkins D. Court grants EPA new hearing on pesticide ban. Capital Press. February 12, 2019; O’Neill E. Will an appeals court make the EPA ban a pesticide linked to serious health risks? The Salt. February 26, 2019. www.npr.org/sections/thesalt/2019/02/26/698227414/will-an-appeals-court-make-the-epa-ban-a-pesticide-linked-to-serious-health-risk. Accessed June 28, 2019.
29. Friedman L. E.P.A. won’t ban chlorpyrifos, pesticide tied to children’s health problems. New York Times. July 18, 2019. www. nytimes.com/2019/07/18/climate/epa-chlorpyrifos-pesticide-ban. html?smid=nytcore-ios-share.
30. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics. 1998;62(3):676–689; Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. The Lancet. 2005;366(9499):1784–1793; Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. Environmental pollutants and breast cancer. Cancer. 2007; 109(S12):2667–2711; McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer – epidemiology, risk factors, and genetics. BMJ. 2000;321(7261):624–628.
31. Hofman A, Stricker BH, Ikram MA, Koudstaal PJ, Darweesh SKL. Trends in the incidence of Parkinson disease in the general population: the Rotterdam Study. American Journal of Epidemiology. 2016;183(11):1018–1026.
32. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience. 2000;3(12):1301–1306.
33. Okun MS. Parkinson’s Treatment: 10 Secrets to a Happier Life (CreateSpace, 2013)/«10 секретов надежды и счастливой жизни с болезнью Паркинсона» Майкл Окун (фрагмент книги опубликован в интернете); Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurology. 2012;11(2):140–149; Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE Trial.